Swanson James D.
SEC CIK 1904785 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | See Remarks | 46.2K | — | $15.27M | 18 | 2022-11-02 | 2026-02-13 |
Most active insiders at JNJ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Duato Joaquin | CEO, COB, Dir | — | $66.84M |
| 2 | Wolk Joseph J | EVP, CFO | — | $21.77M |
| 3 | REED JOHN C | EVP, Innovative Medicine, R, D | — | $17.29M |
| 4 | Swanson James D. | EVP, CIO | — | $15.11M |
| 5 | Schmid Timothy | EVP, WW COB, MedTech | — | $15.08M |
| 6 | Broadhurst Vanessa | EVP, Gbl Corp Affairs | — | $7.30M |
| 7 | Forminard Elizabeth | EVP, CLO | — | $4.09M |
| 8 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | — | $3.95M |
| 9 | Wengel Kathryn E | EVP, Chief TO, Risk Off | — | $2.41M |
| 10 | Decker Robert J | VP Corp. Ctrl | — | $1.01M |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-18 21:12 | 2026-02-13+ | JNJ | Johnson & Johnson | Swanson James D. | EVP, CIO | M - OptEx | $139.50 | +73.1K | 46.2K | New | +$10.20M |
| DM | 2026-02-18 21:12 | 2026-02-13+ | JNJ | Johnson & Johnson | Swanson James D. | EVP, CIO | F - Tax | $244.41 | -4,213 | 25.7K | -14% | -$1.03M |
| DM | 2026-02-18 21:12 | 2026-02-13+ | JNJ | Johnson & Johnson | Swanson James D. | EVP, CIO | S - Sale+OE | $243.39 | -62.1K | 25.7K | -71% | -$15.11M |
| DM | 2025-02-18 21:06 | 2025-02-13+ | JNJ | Johnson & Johnson | Swanson James D. | EVP, CIO | M - OptEx | $0.00 | +6,018 | 19.7K | +44% | $0 |
| DM | 2025-02-18 21:06 | 2025-02-14+ | JNJ | Johnson & Johnson | Swanson James D. | EVP, CIO | F - Tax | $156.54 | -1,740 | 18.8K | -8% | -$272.4K |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Johnson & Johnson | Swanson James D. | EVP, CIO | M - OptEx | $0.00 | +447 | 14.8K | +3% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Johnson & Johnson | Swanson James D. | EVP, CIO | F - Tax | $157.85 | -195 | 14.6K | -1% | -$30.8K |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Johnson & Johnson | Swanson James D. | EVP, CIO | M - OptEx | $0.00 | +5,456 | 16.0K | +52% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Johnson & Johnson | Swanson James D. | EVP, CIO | F - Tax | $157.40 | -1,695 | 14.3K | -11% | -$266.8K |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Johnson & Johnson | Swanson James D. | See Remarks | M - OptEx | $0.00 | +1,868 | 11.1K | +20% | $0 |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Johnson & Johnson | Swanson James D. | See Remarks | F - Tax | $156.33 | -554 | 10.6K | -5% | -$86.6K |
| 2023-03-08 16:16 | 2023-03-06 | JNJ | Johnson & Johnson | Swanson James D. | See Remarks | S - Sale | $154.66 | -1,062 | 9,215 | -10% | -$164.2K | |
| D | 2023-02-15 19:25 | 2023-02-13 | JNJ | Johnson & Johnson | Swanson James D. | See Remarks | A - Grant | $0.00 | +3,228 | 11.2K | +41% | $0 |
| D | 2023-02-15 19:25 | 2023-02-13 | JNJ | Johnson & Johnson | Swanson James D. | See Remarks | F - Tax | $162.01 | -918 | 10.3K | -8% | -$148.7K |
| D | 2023-02-14 16:34 | 2023-02-10 | JNJ | Johnson & Johnson | Swanson James D. | See Remarks | M - OptEx | $0.00 | +1,291 | 8,355 | +18% | $0 |
| D | 2023-02-14 16:34 | 2023-02-10 | JNJ | Johnson & Johnson | Swanson James D. | See Remarks | F - Tax | $162.08 | -388 | 7,967 | -5% | -$62.9K |
| D | 2022-11-04 16:30 | 2022-11-02 | JNJ | Johnson & Johnson | Swanson James D. | EVP, CIO | M - OptEx | $0.00 | +9,912 | 11.0K | +914% | $0 |
| D | 2022-11-04 16:30 | 2022-11-02 | JNJ | Johnson & Johnson | Swanson James D. | EVP, CIO | F - Tax | $172.29 | -3,932 | 7,064 | -36% | -$677.4K |
Purchase Sale Sale after option exercise All abbreviations